alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
The Honorable Richard H. Kyle, United States District Judge for the District of 1 Minnesota. United States Court of Appeals FOR THE EIGHTH CIRCUIT

___________ No. 97-3348

___________ United States of America, * * Appellee, * * Appeal from the United States v. * District Court for the * District of Minnesota. Howard A. McCowan, * * [UNPUBLISHED] Appellant. *

___________ Submitted: January 6, 1998 Filed: January 12, 1998

___________ Before McMILLIAN, FAGG, and BOWMAN, Circuit Judges.

___________ PER CURIAM. In1991, Howard McCowan was convicted of conspiring to distribute cocaine base and possessing cocaine base with intent to distribute, and using a firearm i n relation to drug trafficking. McCowan was sentenced to concurrent prison terms of 121 mo nths on the drug counts and a consecutive 60-month term on the firearm count
. Up onMcCowan & s 28 U.S.C. § 2255 (1994) motion, the District Court vacated hi s 1 firearm conviction in light of Bailey v. United States , 516 U.S. 137, 143-44 (1995).-2-

Afterim posing a two-level enhancement for the possession of a firearm, see U.S
. Sente ncing Guidelines Manual § 2D1.1(b)(1) (1995) (providing for two-leve l enhancement if firearm was in volved), the Court resentenced McCowan to concurrent 151-month prison terms on the drug counts. McCo wan appeals, arguing that the District Court lacked jurisdiction t o resentence him on the unchallenged drug convictions. This argument is foreclosed by Uni ted States v. Harrison , 113 F.3d 135, 137-38 (8th Cir. 1997). After carefull y reviewing McCowan & s remaining points on appeal, we conclude they a re without merit. Accordingly, the judgment is affirmed. A true copy. Attest: CLERK, U.S. COURT OF APPEALS, EIGHTH CIRCUIT.
#### STATE OF NEW JERSEY v. TIMOTHY KAPP.

Dec. 20, 1979.

Petition for certification denied.
Exhibit 13.1

Certification by the Chief Executive Officer

Pursuant to Section 906 of the Sarbanes Oxley Act of 2002

In connection with the Annual Report on Form 20-F of Concord Medical Services Holdings Limited (the Company) for the year ended
December 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Man San Law, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in
all material respects, the financial condition and results of operations of the Company.

Date: March 26, 2014



|    |  |                 |  |                                     
|--- |  | --------------- |  | ------------------------------------
|By: |  | /s/ Man San Law
|    |  | Name:           |  | Man San Law                         
|    |  | Title:          |  | Chairman and Chief Executive Officer
```

[Congressional Record Volume 141, Number 78 (Thursday, May 11, 1995)]
[House]
[Page H4797]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

                          PLEDGE OF ALLEGIANCE

  The SPEAKER pro tempore. Will the gentleman from North Carolina [Mr. 
Jones] come forward and lead the House in the Pledge of Allegiance.
  Mr. JONES led the Pledge of Allegiance as follows:

       I pledge allegiance to the Flag of the United States of 
     America, and to the Republic for which it stands, one nation 
     under God, indivisible, with liberty and justice for all.

                          ____________________
```
```

[Congressional Record Volume 141, Number 78 (Thursday, May 11, 1995)]
[Extensions of Remarks]
[Page E1008]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

               WELCOME TO JESSAMINE COUNTY MIDDLE SCHOOL

                                 ______

                          HON. SCOTTY BAESLER

                              of kentucky

                    in the house of representatives

                         Thursday, May 11, 1995
  Mr. BAESLER. Mr. Speaker, I am delighted to welcome Jessamine County 
Middle School from Nicholasville, KY, to Washington, DC, on their 
annual trip.
  There is a proud history in our Nation's Capital and I am pleased 
that these fine young men and women are able to take advantage of the 
educational opportunities available here in Washington.

                          ____________________
```
[Federal Register Volume 75, Number 178 (Wednesday, September 15, 2010)]
[Notices]
[Pages 56117-56118]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-23017]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections

[[Page 56118]]

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract 
proposals and the discussions could disclose confidential trade secrets 
or commercial property such as patentable material, and personal 
information concerning individuals associated with the contract 
proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Protective Immunity in Special 
Populations.
    Date: October 5-6, 2010.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Crowne Plaza Hotel--Silver Spring, 8777 Georgia Avenue, 
Silver Spring, MD 20910.
    Contact Person: James T. Snyder, PhD, Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities/NIAID, 
National Institutes of Health, 6700B Rockledge Drive, MSC 7616, Room 
<greek-i> 3257, Bethesda, MD 20892-7616, 301-435-1614, 
<a href="/cdn-cgi/l/email-protection#d6bcb7bbb3a5f8a5b8afb2b3a496b8bfbef8b1b9a0"><span class="__cf_email__" data-cfemail="305a515d55431e435e49545542705e59581e575f46">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: September 9, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-23017 Filed 9-14-10; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 32.1



Certification of Chief Executive Officer

Pursuant to

Section 906 of the Sarbanes-Oxley
Act of 2002 (18 U.S.C. 1350)



In connection with the Annual Report on
Form 10-K for the annual period ended December 31, 2013 (the “Report”) of VII Peaks Co-Optivist
Income BDC II, Inc. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I,
Gurpreet S. Chandhoke, the Chief Executive Officer and President, hereby certify, to the best of my knowledge, that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
| | --- | ---------------------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
| | --- | -------------------------------------------------------------------------------------------------------------------------------------------------------



|Dated this 11th day of March, 2014 | By: | /s/ Gurpreet S. Chandhoke                                                                            
|---------------------------------- | --- | -----------------------------------------------------------------------------------------------------
|                                   |     | Gurpreet S. Chandhoke                                                                                
|                                   |     | Chairman of the Board of Directors,Chief Executive Officer and President(Principal Executive Officer)
## United States Court of Appeals FOR THE EIGHTH CIRCUIT

___________ No. 04-3824

___________ William G. Carter, * * Appellant, * Appeal from the United States * District Court for the v. * Eastern District of Missouri. * R. Timothy Bickhaus, P.A., * [UNPUBLISHED] * Appellee, *

___________ Submitted: June 3, 2005 Filed: July 27, 2005

___________ Before BYE, MAGILL, and MELLOY, Circuit Judges.

___________ PER CURIAM. William G. Carter was civilly committed after pleading not guilty by reason of insanity to state criminal charges. He brought this civil-rights action against the state prosecutor, asking for damages, release from custody, and other injunctive relief. The district court dismissed the action under 28 U.S.C § 1915(e)(2)(B), and Carter appeals. We grant Carter leave to appeal in forma pauperis. Having carefully reviewed the record de novo, see Moore v. Sims , 200 F.3d 1170, 1171 (8th Cir. 2000) (per curiam), we conclude for the reasons the district court stated that dismissal of the-2- complaint--insofar as it sought damages and injunctive relief other than release--was proper, in part based on Heck v. Humphrey , 512 U.S. 477, 486-87 (1994). However, we modify the dismissal to be without prejudice. See Sheldon v. Hundley , 83 F.3d 231, 234 (8th Cir. 1996). As for Carter’s request for release, we agree with the district court that such relief is not available under 42 U.S.C. § 1983, but is properly sought in a habeas corpus petition after exhaustion of state remedies. See Preiser v. Rodriguez , 411 U.S. 475, 487-90 (1973). Construing this aspect of the complaint as a habeas petition, see Kruger v. Erickson , 77 F.3d 1071, 1073 (8th Cir. 1996) (per curiam) (court must look to substance of relief sought to determine if action is § 1983 suit or habeas corpus action; prisoner’s labeling of suit is not controlling), we are unable to determine on the record before us whether Carter has fully exhausted the necessary state procedures to challenge his civil commitment. The district court should make this determination after giving Carter the opportunity to demonstrate, through an amended habeas petition, that he has met the exhaustion requirement. Cf. Rhines v. Weber , 125 S. Ct. 1528, 1533-35 (2005) (discussing district court’s options for handling habeas petitions in light of time limitations imposed by 28 U.S.C. § 2244(d)). We suggest the district court reconsider Carter’s motion for appointment of counsel. Accordingly, we affirm in part, as modified, and remand in part for further proceedings consistent with this opinion.

______________________________
# News

## U.S. Air Force LogoUnited States Air Force

# Schriever AFB hosts STEM day event for local students

              - Published  Dec. 11, 2019
              -                             By Airman Amanda Lovelace                                                    
              - 50th Space Wing Public Affairs

**SCHRIEVER AIR FORCE BASE, Colo. (AFNS) --  **
More than 60 middle school students from James Irwin Charter Academy, Colorado Springs, attended a STEM--science, technology, engineering and mathematics--event hosted by the 50th Space Wing Nov. 14 at the Schriever Air Force Base fitness center.“It’s really exciting to get to share what we do here,” said Jan Devitt, 50th SW community support coordinator. “Not a lot of people know about it.”The event included six different booths showcasing basic orbital mechanics, Newton’s laws, Kepler’s laws, virtual reality and radio frequencies and how they can be used to control satellites and send communications and more.Col. Jack Fischer, 50th SW vice commander, briefed the students about STEM and shared some of his experiences as an astronaut.“(Kids) are our future,” he said. “If we don’t inspire them to get into STEM and tackle those hard problems, we’re going to lose. STEM subjects are usually tough in school, so we have to show them how cool it can be, what amazing things they can accomplish if they focus on that. And we’re uniquely suited to show them that because we do so many awesome things.”Airmen from the 50th Operations Support Squadron, 21st Medical Squadron, 2nd Space Operations Squadron, 50th Space Communications Squadron and 50th Security Forces Squadron all came together to show off some of the STEM aspects used here to accomplish the mission.“It’s amazing what our folks do every day, and it’s because they got into STEM,” Fischer said. “We’re trying to light that spark of inspiration early in (kids’) lives so they can contribute and take the baton when we retire.”All of the booths featured ways children could interact with different objects and technology, enabling them to get a tactile, hands-on understanding of some of the basic concepts used every day here.“Anything that exposes kids to new ideas broadens their minds and gives them the opportunity to see so many new things they can be involved in,” Devitt said.Events like this can inspire youth to get involved with something critical to the nation's advancement.“STEM is important, it’s how we progress and evolve as a species,” Fischer said. “It’s how we tackle the hard problems, and if we don’t inspire the next generation to take our place and tackle even harder problems, we’re never going to get any better.”

AFWNUSAFAFAir ForceSchriever Air Force BaseJames Irwin Charter Academyscience technology engineering mathematicsstem50th space wing50th Operations Support Squadron21st Medical Squadron2nd Space Operations Squadron50th Space Communications Squadron50th Security Forces Squadron
Exhibit 99.52
 
  THERATECHNOLOGIES ANNOUNCES A DISTRIBUTION AND LICENSING AGREEMENT FOR  EGRIFTA ® IN LATIN AMERICA, AFRICA AND THE MIDDLE
EAST WITH SANOFI-AVENTIS
 Montréal, Canada  December 6, 2010 EGRIFTA ®
 Terms of the Agreement
 EGRIFTA ® EGRIFTA ® EGRIFTA ® EGRIFTA ® EGRIFTA ® EGRIFTA ®
 EGRIFTA ®
 EGRIFTA ®
 Conference Call and Webcast
 . http://www.theratech.com http://www.gowebcasting.com/2144
 Theratechnologies Inc.
  




---



##### 



About EGRIFTA®
 EGRIFTA ® EGRIFTA ®
 About HIV-Associated Lipodystrophy
  About Theratechnologies
 EGRIFTA ®
 www.theratech.com
 About sanofi-aventis
  http://www.sanofi-aventis.com
 Forward-Looking Information
  EGRIFTA ®
 2




---



##### 



EGRIFTA ® EGRIFTA ® EGRIFTA ®
   communications@theratech.com
 3
Exhibit 99.41
 
 News Release
 Theratechnologies Announces Filing of European Marketing Authorization
Application for Tesamorelin
 Montréal, Canada  June 6, 2011
    EGRIFTA ®
  About EGRIFTA ®
 EGRIFTA ®




---



##### 



1
 About HIV-Associated Lipodystrophy
  About Theratechnologies
 EGRIFTA ® EGRIFTA ® EGRIFTA ®
 EGRIFTA ® EGRIFTA ® EGRIFTA ®
 Additional Information about Theratechnologies
  Forward-Looking Information
   2




---



##### 



1 Grunfeld C et al. J Acquir Immune Defic Syndr; 45:286-297 (2007). Lo J et al. JAMA,
300: 509518 (2008).
 Contact:
 3
Exhibit 32

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of Cardium Therapeutics, Inc., a
Delaware corporation, does hereby certify, to such officers knowledge, that the Quarterly Report on Form 10-QSB for the quarterly period ended March 31, 2006 of Cardium Therapeutics, Inc. fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)) and that information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Cardium Therapeutics, Inc.



|                   |  |                                                 
|------------------ |  | ------------------------------------------------
|Date: May 15, 2006 |  | /s/ Christopher J. Reinhard                     
|                   |  | Christopher J. Reinhard, Chief Executive Officer
|                   | 
|Date: May 15, 2006 |  | /s/ Dennis M. Mulroy                            
|                   |  | Dennis M. Mulroy, Chief Financial Officer       

The foregoing certification is furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Form 10-QSB or as a separate disclosure document.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Child Health and Human Development Initial Review Group; Developmental Biology Subcommittee.                    

*Date:*                         October 13-15, 2010.                    

*Time:*                         7 p.m. to 4:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Doubletree Hotel Washington, 1515 Rhode Island Avenue, NW., Washington, DC 20005.                    

*Contact Person:*                         Norman Chang, PhD, Scientific Review Officer, Division of Scientific Review, Eunice Kennedy Shriver National Institute of Child Health And Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892. (301) 496-1485.                         *changn@mail.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS)

Dated: September 8, 2010.

Jennifer S. Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-23014 Filed 9-14-10; 8:45 am]

BILLING CODE 4140-01-P
EXHIBIT 32.2





CERTIFICATION PURSUANT TO
 18 U.S.C. Section 1350,
 AS ADOPTED PURSUANT TO
 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of DiscountCoupons Corporation (the “Company”) on Form 10-K for the period endedDecember 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “report”), I, Pat Martin, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:





(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)
The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





Dated this 8th day of August 2014
/s/ Pat MartinPat MartinPrincipal Financial Officer
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
consolidated financial statements of American Business Financial Services, Inc.
and Subsidiaries as of March 31, 1999 and the nine months then ended and is
qualified in its entirety by reference to such financial statements.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JUN-30-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                      20,876,966
<SECURITIES>                                         0
<RECEIVABLES>                               61,056,249
<ALLOWANCES>                                 1,006,505
<INVENTORY>                                          0
<CURRENT-ASSETS>                           131,477,424
<PP&E>                                      16,372,338
<DEPRECIATION>                               6,295,460
<TOTAL-ASSETS>                             327,400,255
<CURRENT-LIABILITIES>                      169,667,371
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         3,527
<OTHER-SE>                                  54,034,616
<TOTAL-LIABILITY-AND-EQUITY>               327,400,255
<SALES>                                              0
<TOTAL-REVENUES>                            61,209,293
<CGS>                                                0
<TOTAL-COSTS>                               45,078,348
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                               745,269
<INTEREST-EXPENSE>                          15,674,620
<INCOME-PRETAX>                             16,130,945
<INCOME-TAX>                                 5,704,080
<INCOME-CONTINUING>                         10,426,865
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                10,426,865
<EPS-PRIMARY>                                     2.96
<EPS-DILUTED>                                     2.87
        

</TABLE>